SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-277874
Filing Date
2019-10-29
Accepted
2019-10-29 19:18:25
Documents
14
Period of Report
2019-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d780589d8k.htm   iXBRL 8-K 32152
2 EX-1.1 d780589dex11.htm EX-1.1 204430
3 EX-5.1 d780589dex51.htm EX-5.1 12307
  Complete submission text file 0001193125-19-277874.txt   428883

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA opk-20191024.xsd EX-101.SCH 3056
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20191024_lab.xml EX-101.LAB 17375
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20191024_pre.xml EX-101.PRE 10945
10 EXTRACTED XBRL INSTANCE DOCUMENT d780589d8k_htm.xml XML 3222
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 191176648
SIC: 2834 Pharmaceutical Preparations